Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development

Molecules

Volumn 14, Issue 9, 2009, Pages 3509-3527

  Carlson, Bradley A ^a   Yoo, Min Hyuk ^a   Tsuji, Petra A ^a   Gladyshev, Vadim N ^b   Hatfield, Dolph L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Mouse models; Selenium; Selenocysteine tRNA; Selenoproteins

Indexed keywords

SELENOPROTEIN; TRANSFER RNA; TRNA, SELENOCYSTEINE; TRNA, SELENOCYSTEINE-;

ANIMAL; ANIMAL MODEL; CHEMISTRY; CONFORMATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEALTH; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; REVIEW;

ANIMALS; BASE SEQUENCE; GROWTH AND DEVELOPMENT; HEALTH; MICE; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RNA, TRANSFER, AMINO ACID-SPECIFIC; SELENOPROTEINS;

EID: 70349559748     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14093509     Document Type: Review

References (78)

1. Hatfield, D.L.; Berry, M.J.; Gladyshev, V.N. Selenium: Its Molecular Biology and Role in Human Health; Springer Science+Business Media, LLC: New York, NY, USA, 2006.
2. Birringer, M.; Pilawa, S.; Flohe, L. Trends in selenium biochemistry. Nat. Prod. Rep. 2002, 19, 693-718.
3. Hatfield, D.L.; Gladyshev, V.N. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 2002, 22, 3565-3576, 4.
4. Stadtman, T.C. Discoveries of vitamin B12 and selenium enzymes. Annu. Rev. Biochem. 2002, 71, 1-16.
5. Hatfield, D.L.; Choi, I.S.; Ohama, T.; Jung, J.E.; Diamond, A.M.: Selenocysteine tRNA(Ser)sec isoacceptors as central components in selenoprotein biosynthesis in eukaryotes. In Selenium in Biology and Human Health; Burk, R.F., Ed.; Springer-Verlag: New York, NY, USA, 1994, pp. 25-44.
6. Xu, X.M.; Carlson, B.A.; Mix, H.; Zhang, Y.; Saira, K.; Glass, R.S.; Berry, M.J.; Gladyshev, V.N.; Hatfield, D.L. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2006, 5, e4.
7. Yuan, J.; Palioura, S.; Salazar, J.C.; Su, D.; O'Donoghue, P.; Hohn, M.J.; Cardoso, A.M.; Whitman, W.B.; Soll, D. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc. Natl. Acad. Sci. USA 2006, 103, 18923-18927.
8. Kryukov, G.V.; Castellano, S.; Novoselov, S.V.; Lobanov, A.V.; Zehtab, O.; Guigo, R.; Gladyshev, V.N. Characterization of mammalian selenoproteomes. Science 2003, 300, 1439-1443.
9. Moustafa, M.E.; Carlson, B.A.; El-Saadani, M.A.; Kryukov, G.V.; Sun, Q.A.; Harney, J.W.; Hill, K.E.; Combs, G.F.; Feigenbaum, L.; Mansur, D.B.; Burk, R.F.; Berry, M.J.; Diamond, A.M.; Lee, B.J.; Gladyshev, V.N.; Hatfield, D.L. Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine- deficientselenocysteine tRNA. Mol. Cell. Biol. 2001, 21, 3840-3852.
10. Carlson, B.A.; Xu, X.M.; Gladyshev, V.N.; Hatfield, D.L. Selective rescue of selenoprotein expression in mice lacking a highly specialized methyl group in selenocysteine tRNA. J. Biol. Chem. 2005, 250, 5542-5548.
11. Kumaraswamy, E.; Carlson, B.A.; Morgan, F.; Miyoshi, K.; Robinson, G.W.; Su, D.; Wang, S.; Southon, E.; Tessarollo, L.; Lee, B.J.; Gladyshev, V.N.; Hennighausen, L.; Hatfield, D.L. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol. Cell. Biol. 2003, 23, 1477-1488.
12. Carlson, B.A.; Novoselov, S.V.; Kumaraswamy, E.; Lee, B.J.; Anver, M.R.; Gladyshev, V.N.; Hatfield, D.L. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J. Biol. Chem. 2004, 279, 8011-8017.
13. Ho, Y.S.; Magnenat, J.L.; Bronson, R.T.; Cao, J.; Gargano, M.; Sugawara, M.; Funk, C.D. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J. Biol. Chem. 1997, 272, 16644-16651.
14. Esworthy, R.S.; Mann, J.R.; Sam, M.; Chu, F.F. Low glutathione peroxidase activity in Gpx1 knockout mice protects jejunum crypts from gamma-irradiation damage. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279, G426-436.
15. Esworthy, R.S.; Aranda, R.; Martin, M.G.; Doroshow, J.H.; Binder, S.W.; Chu, F.F. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G848-855.
16. Yant, L.J.; Ran, Q.; Rao, L.; Van Remmen, H.; Shibatani, T.; Belter, J.G.; Motta, L.; Richardson, A.; Prolla, T.A. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 2003, 34, 496-502.
17. Jakupoglu, C.; Przemeck, G.K.; Schneider, M.; Moreno, S.G.; Mayr, N.; Hatzopoulos, A.K.; de Angelis, M.H.; Wurst, W.; Bornkamm, G.W.; Brielmeier, M.; Conrad, M. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol. Cell. Biol. 2005, 25, 1980-1988.
18. Conrad, M.; Jakupoglu, C.; Moreno, S.G.; Lippl, S.; Banjac, A.; Schneider, M.; Beck, H.; Hatzopoulos, A.K.; Just, U.; Sinowatz, F.; Schmahl, W.; Chien, K.R.; Wurst, W.; Bornkamm, G.W.; Brielmeier, M. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol. Cell. Biol. 2004, 24, 9414-9423.
19. Schneider, M.J.; Fiering, S.N.; Thai, B.; Wu, S.Y.; St Germain, E.; Parlow, A.F.; St Germain, D.L.; Galton, V.A. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 2006, 147, 580-589.
20. Schneider, M.J.; Fiering, S.N.; Pallud, S.E.; Parlow, A.F.; St Germain, D.L.; Galton, V.A. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 2001, 15, 2137-2148.
21. Galton, V.A.; Schneider, M.J.; Clark, A.S.; St Germain, D.L. Life without thyroxine to 3,5,3'- triiodothyronine conversion: studies in mice devoid of the 5'-deiodinases. Endocrinology 2009, 150, 2957-2963.
22. Hernandez, A.; Martinez, M.E.; Fiering, S.; Galton, V.A.; St Germain, D. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J. Clin. Invest. 2006, 116, 476-484.
23. Schomburg, L.; Schweizer, U.; Holtmann, B.; Flohe, L.; Sendtner, M.; Kohrle, J. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem. J. 2003, 370, 397-402.
24. Hill, K.E.; Zhou, J.; McMahan, W.J.; Motley, A.K.; Burk, R.F. Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J. Nutr. 2004, 134, 157-161.
25. Fomenko, D.E.; Novoselov, S.V.; Natarajan, S.K.; Lee, B.C.; Koc, A.; Carlson, B.A.; Lee, T.H.; Kim, H.Y.; Hatfield, D.L.; Gladyshev, V.N. MsrB1 (methionine-R-sulfoxide reductase 1) knockout mice: roles of MsrB1 in redox regulation and identification of a novel selenoprotein form. J. Biol. Chem. 2009, 284, 5986-5993.
26. Conrad, M.; Schweizer, U. Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid. Redox Signal. 2009, in press.
27. Bosl, M.R.; Takaku, K.; Oshima, M.; Nishimura, S.; Taketo, M.M. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 1997, 94, 5531-5534.
28. Carlson, B.A.; Moustafa, M.E.; Sengupta, A.; Schweizer, U.; Shrimali, R.; Rao, M.; Zhong, N.; Wang, S.; Feigenbaum, L.; Lee, B.J.; Gladyshev, V.N.; Hatfield, D.L. Selective restoration of the selenoprotein population in a mouse hepatocyte selenoproteinless background with different mutant selenocysteine tRNAs lacking Um34. J. Biol. Chem. 2007, 252, 32591-32602.
29. Diamond, A.M.; Choi, I.S.; Crain, P.F.; Hashizume, T.; Pomerantz, S.C.; Cruz, R.; Steer, C.J.; Hill, K.E.; Burk, R.F.; McCloskey, J.A.; et al. Dietary selenium affects methylation of the wobble nucleoside in the anticodon of selenocysteine tRNA([Ser]Sec). J. Biol. Chem. 1993, 268, 14215-14223.
30. Choi, I.S.; Diamond, A.M.; Crain, P.F.; Kolker, J.D.; McCloskey, J.A.; Hatfield, D.L.Reconstitution of the biosynthetic pathway of selenocysteine tRNAs in Xenopus oocytes. Biochemistry 1994, 33, 601-605.
31. Kim, L.K.; Matsufuji, T.; Matsufuji, S.; Carlson, B.A.; Kim, S.S.; Hatfield, D.L.; Lee, B.J. Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA[Ser]Sec is governed by both primary and tertiary structure. RNA 2000, 6, 1306-1315.
32. Hatfield, D.; Lee, B.J.; Hampton, L.; Diamond, A.M. Selenium induces changes in the selenocysteine tRNA[Ser]Sec population in mammalian cells. Nucleic Acids Res. 1991, 19, 939-943.
33. Hatfield, D.L.; Carlson, B.A.; Xu, X.M.; Mix, H.; Gladyshev, V.N. Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Prog. Nucleic Acid Res. Mol. Biol. 2006, 81, 97-142.
34. Sun, X.; Li, X.; Moriarty, P.M.; Henics, T.; LaDuca, J.P.; Maquat, L.E. Nonsense-mediated decay of mRNA for the selenoprotein phospholipid hydroperoxide glutathione peroxidase is detectable in cultured cells but masked or inhibited in rat tissues. Mol. Biol. Cell 2001, 12, 1009-1017.
35. Weiss, S.L.; Sunde, R.A. Cis-acting elements are required for selenium regulation of glutathione peroxidase-1 mRNA levels. RNA 1998, 4, 816-827.
36. Brigelius-Flohe, R. Selenium compounds and selenoproteins in cancer. Chem. Biodivers. 2008, 5, 389-395.
37. Rayman, M.P. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc. Nutr. Soc. 2005, 64, 527-542.
38. Ip, C.; Hayes, C.; Budnick, R.M.; Ganther, H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 1991, 51, 595-600.
39. Lu, J.; Jiang, C. Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid. Redox Signal. 2005, 7, 1715-1727.
40. Irons, R.; Carlson, B.A.; Hatfield, D.L.; Davis, C.D. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression. J. Nutr. 2006, 136, 1311-1317.
41. Kipp, A.; Banning, A.; Schothorst, E.M.v.; Meplan, C.; Schomburg, L.; Evelo, C.; Coort, S.; Gaj, S.; Keijer, J.; Hesketh, J.; Brigelius-Flohe, R. Four selenoproteins, protein biosynthesis, and Wnt signalling are particularly sensitive to selenium intake in mouse colon. Mol. Nutr. Food Res. 2009, in press.
42. Diwadkar-Navsariwala, V.; Prins, G.S.; Swanson, S.M.; Birch, L.A.; Ray, V.H.; Hedayat, S.; Lantvit, D.L.; Diamond, A.M. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. Proc. Natl. Acad. Sci. USA 2006, 103, 8179-8184.
43. Hoffmann, P.R. Mechanisms by which selenium influences immune responses. Arch. Immunol. Ther. Exp. (Warsz) 2007, 55, 289-297.
44. Hoffmann, P.R.; Berry, M.J. The influence of selenium on immune responses. Mol. Nutr. Food Res. 2008, 52, 1273-1280.
45. Shrimali, R.K.; Irons, R.D.; Carlson, B.A.; Sano, Y.; Gladyshev, V.N.; Park, J.M.; Hatfield, D.L. Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 2008, 283, 20181-20185.
46. Suzuki, T.; Kelly, V.P.; Motohashi, H.; Nakajima, O.; Takahashi, S.; Nishimura, S.; Yamamoto, M. Deletion of the selenocysteine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2. J. Biol. Chem. 2008, 283, 2021-2030.
47. Kolsteren, P. Kashin-Beck disease. Ann. Soc. Belg. Med. Trop. 1992, 72, 81-91.
48. Downey, C.M.; Horton, C.R.; Carlson, B.A.; Parsons, T.E.; Hatfield, D.L.; Hallgriacute;msson, B.; Jirik, F.R. Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet. 2009, in press.
49. Ge, K.; Xue, A.; Bai, J.; Wang, S. Keshan disease-an endemic cardiomyopathy in China. Virchows Arch. A Pathol. Anat. Histopathol. 1983, 401, 1-15.
50. Cheng, Y.Y.; Qian, P.C. The effect of selenium-fortified table salt in the prevention of Keshan disease on a population of 1.05 million. Biomed. Environ. Sci. 1990, 3, 422-428.
51. Beck, M.A.; Levander, O.A.; Handy, J. Selenium deficiency and viral infection. J. Nutr. 2003, 133, 1463S-1467S.
52. Gao, J.; Xiong, Y.; Ho, Y.S.; Liu, X.; Chua, C.C.; Xu, X.; Wang, H.; Hamdy, R.; Chua, B.H.Glutathione peroxidase 1-deficient mice are more susceptible to doxorubicin-induced cardiotoxicity. Biochim. Biophys. Acta 2008, 1783, 2020-2029.
53. Shrimali, R.K.; Weaver, J.A.; Miller, G.F.; Starost, M.F.; Carlson, B.A.; Novoselov, S.V.;Kumaraswamy, E.; Gladyshev, V.N.; Hatfield, D.L. Selenoprotein expression is essential in endothelial cell development and cardiac muscle function. Neuromuscul. Disord. 2007, 17, 135-142.
54. Moustafa, M.E.; El-Saadani, M.A.; Kandeel, K.M.; Mansur, D.B.; Lee, B.J.; Hatfield, D.L.; Diamond, A.M. Overproduction of selenocysteine tRNA in Chinese hamster ovary cells following transfection of the mouse tRNA[Ser]Sec gene. RNA 1998, 4, 1436-1443.
55. Sengupta, A.; Carlson, B.A.; Hoffmann, V.J.; Gladyshev, V.N.; Hatfield, D.L. Loss of housekeeping selenoprotein expression in mouse liver modulates lipoprotein metabolism. Biochem. Biophys. Res. Commun. 2008, 365, 446-452.
56. Kelly, V.P.; Suzuki, T.; Nakajima, O.; Arai, T.; Tamai, Y.; Takahashi, S.; Nishimura, S.; Yamamoto, M. The distal sequence element of the selenocysteine tRNA gene is a tissue- dependent enhancer essential for mouse embryogenesis. Mol. Cell. Biol. 2005, 25, 3658-3669.
57. Carlson, B.A.; Schweizer, U.; Perella, C.; Shrimali, R.K.; Feigenbaum, L.; Shen, L.; Speransky, S.; Floss, T.; Jeong, S.J.; Watts, J.; Hoffmann, V.; Combs, G.F.; Gladyshev, V.N.; Hatfield, D.L.The selenocysteine tRNA STAF-binding region is essential for adequate selenocysteine tRNA status, selenoprotein expression and early age survival of mice. Biochem. J. 2009, 418, 61-71.
58. Lee, B.J.; de la Pena, P.; Tobian, J.A.; Zasloff, M.; Hatfield, D. Unique pathway of expression of an opal suppressor phosphoserine tRNA. Proc. Natl. Acad. Sci. USA 1987, 84, 6384-6388.
59. Lee, B.J.; Kang, S.G.; Hatfield, D. Transcription of Xenopus selenocysteine tRNA Ser (formerly designated opal suppressor phosphoserine tRNA) gene is directed by multiple 5'-extragenic regulatory elements. J. Biol. Chem. 1989, 264, 9696-9702.
60. Myslinski, E.; Krol, A.; Carbon, P. Optimal tRNA((Ser)Sec) gene activity requires an upstream SPH motif. Nucleic Acids Res. 1992, 20, 203-209.
61. Park, J.M.; Choi, I.S.; Kang, S.G.; Lee, J.Y.; Hatfield, D.L.; Lee, B.J. Upstream promoter elements are sufficient for selenocysteine tRNA[Ser]Sec gene transcription and to determine the transcription start point. Gene 1995, 162, 13-19.
62. Adachi, K.; Katsuyama, M.; Song, S.; Oka, T. Genomic organization, chromosomal mapping and promoter analysis of the mouse selenocysteine tRNA gene transcription-activating factor (mStaf) gene. Biochem. J. 2000, 346 (Pt 1), 45-51.
63. Adachi, K.; Saito, H.; Tanaka, T.; Oka, T. Molecular cloning and characterization of the murine staf cDNA encoding a transcription activating factor for the selenocysteine tRNA gene in mouse mammary gland. J. Biol. Chem. 1998, 273, 8598-8606.
64. Adachi, K.; Tanaka, T.; Saito, H.; Oka, T. Hormonal induction of mouse selenocysteine transfer ribonucleic acid (tRNA) gene transcription-activating factor and its functional importance in the selenocysteine tRNA gene transcription in mouse mammary gland. Endocrinology 1999, 140, 618-623.
65. Schuster, C.; Myslinski, E.; Krol, A.; Carbon, P. Staf, a novel zinc finger protein that activates the RNA polymerase III promoter of the selenocysteine tRNA gene. EMBO J. 1995, 14, 3777-3787.
66. Barski, O.A.; Papusha, V.Z.; Kunkel, G.R.; Gabbay, K.H. Regulation of aldehyde reductase expression by STAF and CHOP. Genomics 2004, 83, 119-129.
67. Schaub, M.; Krol, A.; Carbon, P. Flexible zinc finger requirement for binding of the transcriptional activator staf to U6 small nuclear RNA and tRNA(Sec) promoters. J. Biol. Chem. 1999, 274, 24241-24249.
68. Schaub, M.; Myslinski, E.; Krol, A.; Carbon, P. Maximization of selenocysteine tRNA and U6 small nuclear RNA transcriptional activation achieved by flexible utilization of a Staf zinc finger. J. Biol. Chem. 1999, 274, 25042-25050.
69. Schaub, M.; Myslinski, E.; Schuster, C.; Krol, A.; Carbon, P. Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III. EMBO J. 1997, 16, 173-181.
70. Hatfield, D.; Gladyshev, V.; Park, J.M.; Park, S.I.; Chittum, H.; Huh, J.; Carlson, B.; Kim, M.; Moustafa, M.; Lee, B.J.: Biosynthesis of selenocysteine and its incorporation into protein as the 21st amino acid. In Comprehensive Natural Products Chemistry, Kelly, J.W., Ed.; Elsevier Science, Oxford, U.K., 1999, Vol.4, pp. 353-380.
71. Schweizer, U.; Michaelis, M.; Kohrle, J.; Schomburg, L. Efficient selenium transfer from mother to offspring in selenoprotein-P-deficient mice enables dose-dependent rescue of phenotypes associated with selenium deficiency. Biochem. J. 2004, 378, 21-26.
72. Hornberger, T.A.; McLoughlin, T.J.; Leszczynski, J.K.; Armstrong, D.D.; Jameson, R.R.; Bowen, P.E.; Hwang, E.S.; Hou, H.; Moustafa, M.E.; Carlson, B.A.; Hatfield, D.L.; Diamond, A.M.; Esser, K.A. Selenoprotein-deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J. Nutr. 2003, 133, 3091-3097.
73. Baliga, M.S.; Diwadkar-Navsariwala, V.; Koh, T.; Fayad, R.; Fantuzzi, G.; Diamond, A.M. Selenoprotein deficiency enhances radiation-induced micronuclei formation. Mol. Nutr. Food Res. 2008, 52, 1300-1304.
74. Sheridan, P.A.; Zhong, N.; Carlson, B.A.; Perella, C.M.; Hatfield, D.L.; Beck, M.A. Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. J. Nutr. 2007, 137, 1466-1471.
75. Schweizer, U.; Streckfuss, F.; Pelt, P.; Carlson, B.A.; Hatfield, D.L.; Köhrle, J.; Schomburg, L. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 2005, 386, 221-226.
76. Streckfuss, F.; Hamann, I.; Schomburg, L.; Michaelis, M.; Sapin, R.; Klein, M.O.; Kohrle, J.; Schweizer, U. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochem. Biophys. Res. Commun. 2005, 337, 739-745.
77. Blauwkamp, M.N.; Yu, J.; Schin, M.A.; Burke, K.A.; Berry, M.J.; Carlson, B.A.; Brosius, F.C., 3rd; Koenig, R.J. Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol. 2008, 9, 7.
78. Sengupta, A.; Carlson, B.A.; Weaver, J.A.; Novoselov, S.V.; Fomenko, D.E.; Gladyshev, V.N.; Hatfield, D.L. A functional link between housekeeping selenoproteins and phase II enzymes. Biochem. J. 2008, 413, 151-161.